Article Per Year (5 Year)
p-Index From 2019 - 2024
0.444
P-Index
This Author published in this journals
All Journal Jurnal Kebijakan Kesehatan Indonesia Journal of the Medical Sciences (Berkala Ilmu Kedokteran)
Sidhi Laksono
Fakultas Kedokteran Universitas UHAMKA
Immunology & microbiology Neuroscience Public Health

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Kesehatan Digital dan Disrupsi Digital pada Layanan Kesehatan di Rumah Sakit Sidhi Laksono
Jurnal Kebijakan Kesehatan Indonesia Vol 11, No 1 (2022)
Publisher : Center for Health Policy and Management

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22146/jkki.63254

Abstract

Kesehatan digital mengubah penyediaan layanan kesehatan di seluruh dunia untuk memenuhi tantangan yang terus berkembang akibat bertambahnya populasi yang menua dengan berbagai kondisi kronis. Transformasi digital dan inovasi disruptif menggambarkan reorientasi komprehensif industri termasuk model bisnisnya karena datangnya zaman teknologi digital yang berupa digitalisasi produk, layanan, dan proses. Adapun produk kesehatan digital dapat berupa kesehatan elektronik (eHealth), kesehatan seluler (mHealth), teknologi informasi kesehatan, telekesehatan atau telekonsultasi (telehealth/telemedicine). Semua produk digital tersebut, jika tidak bisa diaplikasikan dalam waktu sekarang dan mendatang akan menyebabkan disrupsi digital dalam layanan kesehatan tradisional di RS. Artikel ini akan membahas secara singkat mengenai kesehatan digital dan disrupsi digital pada layanan kesehatan di RS.
Angiotensin converting enzyme 2 (ACE2), COVID-19 and cardiac injury: what cardiologist should know Sidhi Laksono; Budhi Setianto; Steven Philip Surya
Journal of the Medical Sciences (Berkala Ilmu Kedokteran) Vol 52, No 3 (2020): Special Issue: COVID-19
Publisher : Journal of the Medical Sciences (Berkala Ilmu Kedokteran)

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (197.966 KB) | DOI: 10.19106/JMedSciSI005203202009

Abstract

Coronavirus disease 2019 (COVID-19) has already stated as a pandemic by the World Health Organization (WHO). Until now, Indonesia has also infected with this severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. All medical staffs join hand by hand to overcome this pandemic, not only pulmonologist but also cardiologist. Early reports from China showed that cardiovascular comorbidities add more mortality than without comorbid. Cardiac implication of this infection is cardiac injury. Viral pathology and pathophysiology that induced cardiac injury is still debatable and not well understood. Angiotensin-converting enzyme 2 (ACE2) has emerged as a key regulator of renin-angiotensin system in cardiovascular disease. ACE2 has been postulated as one of the pathophysiology of COVID-19 and cardiac injury.
Co-Authors Budhi Setianto Steven Philip Surya